Minerva Neurosciences (NERV) Stock Chart & Stock Price History → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free NERV Stock Alerts $2.48 -0.04 (-1.59%) (As of 04:27 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Minerva Neurosciences Stock Price Performance5 Day Performance-3.69%1 Month Performance0.00%3 Month Performance-71.82%6 Month Performance-49.80%Year-To-Date Performance-59.67%1 Year Performance-63.04% Receive NERV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). NERV Stock Chart for Monday, May, 20, 2024 NERV Chart by TradingView Minerva Neurosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$2.57$2.52-1.90%$2.54$2.522,186 shs$17.62 million05/16/2024$2.58$2.57-0.24%$2.59$2.505,340 shs$17.96 million05/15/2024$2.48$2.58+3.83%$2.59$2.5010,622 shs$18.00 million05/14/2024$2.48$2.48$2.60$2.4517,045 shs$17.34 million05/13/2024$2.39$2.48+3.77%$2.48$2.4113,467 shs$17.34 million05/10/2024$2.51$2.39-4.78%$2.51$2.3520,962 shs$16.71 million Get the Latest News and Ratings for NERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$2.51$2.51$2.58$2.502,153 shs$17.55 million05/08/2024$2.49$2.51+0.80%$2.53$2.455,216 shs$17.55 million05/07/2024$2.34$2.49+6.41%$2.58$2.3331,293 shs$17.41 million05/06/2024$2.37$2.34-1.27%$2.41$2.349,314 shs$16.36 million05/03/2024$2.35$2.37+0.85%$2.41$2.3615,458 shs$16.57 million05/02/2024$2.40$2.35-2.08%$2.44$2.338,821 shs$16.43 million05/01/2024$2.36$2.40+1.70%$2.41$2.3115,775 shs$16.78 million04/30/2024$2.41$2.36-2.08%$2.40$2.3419,262 shs$16.50 million04/29/2024$2.44$2.41-1.09%$2.48$2.4110,961 shs$16.85 million04/26/2024$2.45$2.44-0.55%$2.49$2.434,157 shs$17.03 million04/25/2024$2.52$2.45-2.78%$2.51$2.435,770 shs$17.13 million04/24/2024$2.53$2.52-0.40%$2.53$2.473,943 shs$17.62 million04/23/2024$2.55$2.53-0.78%$2.59$2.494,576 shs$17.69 million04/22/2024$2.48$2.55+2.82%$2.58$2.4410,036 shs$17.82 million04/19/2024$2.51$2.48-1.20%$2.53$2.4511,384 shs$17.34 million04/18/2024$2.47$2.51+1.62%$2.52$2.3914,192 shs$17.55 million04/17/2024$2.50$2.47-1.20%$2.55$2.4015,670 shs$17.27 million04/16/2024$2.42$2.50+3.31%$2.80$2.3568,552 shs$17.48 million04/15/2024$2.50$2.42-3.20%$2.50$2.2930,348 shs$16.92 million04/12/2024$2.54$2.50-1.57%$2.57$2.4515,182 shs$17.48 million04/11/2024$2.47$2.54+2.83%$2.57$2.4114,230 shs$17.76 million04/10/2024$2.54$2.47-2.76%$2.53$2.437,637 shs$17.27 million04/09/2024$2.54$2.54$2.54$2.4523,444 shs$17.76 million04/08/2024$2.54$2.54$2.54$2.4910,380 shs$17.76 million04/05/2024$2.53$2.54+0.40%$2.56$2.4247,245 shs$17.76 million04/04/2024$2.54$2.53-0.39%$2.59$2.499,670 shs$17.69 million04/03/2024$2.52$2.54+0.99%$2.58$2.4715,263 shs$17.76 million04/02/2024$2.56$2.52-1.76%$2.55$2.4810,195 shs$17.58 million04/01/2024$2.58$2.56-0.78%$2.61$2.519,530 shs$17.89 million03/29/2024$2.58$2.58$2.59$2.4528,283 shs$18.03 million03/28/2024$2.52$2.58+2.38%$2.58$2.4528,283 shs$18.03 million03/27/2024$2.57$2.52-1.95%$2.62$2.4434,727 shs$17.62 million03/26/2024$2.66$2.57-3.38%$2.65$2.5236,787 shs$17.96 million03/25/2024$2.67$2.66-0.37%$2.75$2.6012,238 shs$18.59 millionEverybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade.03/22/2024$2.59$2.67+3.09%$2.68$2.5728,421 shs$18.66 million03/21/2024$2.70$2.59-4.07%$2.78$2.5634,416 shs$18.10 million03/20/2024$2.65$2.70+1.89%$2.77$2.6324,079 shs$18.88 million03/19/2024$2.70$2.65-1.85%$2.78$2.6516,339 shs$18.52 million03/18/2024$2.79$2.70-3.23%$2.85$2.6640,771 shs$18.87 million03/15/2024$2.75$2.79+1.45%$2.80$2.7559,128 shs$19.51 million03/14/2024$2.82$2.75-2.48%$2.78$2.7059,427 shs$19.22 million03/13/2024$2.77$2.82+1.81%$2.92$2.7578,912 shs$19.71 million03/12/2024$2.81$2.77-1.42%$2.91$2.67170,350 shs$19.36 million03/11/2024$2.80$2.81+0.36%$2.91$2.60295,722 shs$19.64 million03/08/2024$2.56$2.80+9.37%$2.87$2.54200,248 shs$19.57 million03/07/2024$2.60$2.56-1.54%$2.63$2.5366,971 shs$17.89 million03/06/2024$2.60$2.60$2.69$2.5453,790 shs$18.17 million03/05/2024$2.58$2.60+0.78%$2.63$2.4890,611 shs$18.17 million03/04/2024$2.63$2.58-1.90%$2.65$2.47153,505 shs$18.03 million03/01/2024$2.67$2.63-1.50%$2.81$2.40730,175 shs$18.39 million02/29/2024$2.83$2.67-5.65%$3.03$2.66239,995 shs$18.66 million02/28/2024$2.80$2.83+1.07%$3.19$2.78438,458 shs$19.78 million02/27/2024$6.80$2.80-58.82%$3.40$2.631.93 million shs$19.57 million02/26/2024$6.87$6.80-1.02%$7.53$6.55405,397 shs$47.53 million02/23/2024$7.25$6.87-5.24%$8.20$5.81418,464 shs$48.02 million02/22/2024$8.80$7.25-17.61%$9.40$7.00206,092 shs$50.68 million02/21/2024$8.80$8.80$9.28$8.5388,700 shs$61.51 million02/20/2024$8.39$8.80+4.89%$9.09$8.4734,182 shs$61.51 million02/19/2024$8.39$8.39$9.84$8.1859,600 shs$58.65 million Related Companies: Talphera Stock Price Chart GlycoMimetics Stock Price Chart Traws Pharma Stock Price Chart Flora Growth Stock Price Chart VBI Vaccines Stock Price Chart Vincerx Pharma Stock Price Chart Galecto Stock Price Chart Aytu BioPharma Stock Price Chart Sol-Gel Technologies Stock Price Chart Indaptus Therapeutics Stock Price Chart Receive NERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NERV) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.